Thank you for your interest. The I-MOVE+ project (2015-2018) is over, and this website will no longer be updated. However, activities to monitor vaccine effectiveness in Europe are ongoing and can be found on the I-MOVE and SpiDnet websites for influenza (coming soon) and pneumococcal vaccines (

Countries participating in I-MOVE+ 

I-MOVE+ (Integrated Monitoring of Vaccines in Europe) is a consortium of 26 partners (regional and national public health Institutes, SME, Universities frrom of 15 European Union / European Economic Area Member States.

 Its goal is to develop a sustainable platform of primary care, hospital and laboratory networks that use  validated  standardised  methods  to  evaluate existing  and  new  vaccines programmes independently from commercial interests.

I-MOVE+ has received a grant (May 2015- Oct 2018) from the European Commission (H2020) to identify, pilot test, use, and disseminate the best study designs to measure, in near real time the effectiveness and impact of vaccines used in the elderly population to prevent influenza and pneumococcal infections.